The 3rd International Online Conference on Genes
The 3rd International Online Conference on Genes
Part of the International Electronic Conference on Genes series
Event's Timezone: Central European Time
4 August 2026
30 September 2026
26 November 2026
human genomics, medical genetics, functional genomics, precision medicine
The IOCGE 2026 is Now OPEN for Abstract Submission and Registration.
Instructions for authors are available online.
Submit your abstracts HERE.
For any inquiries, please contact us at iocge2026@mdpi.com.
Welcome from the Chair
Dear Colleagues,
We are delighted to announce the 3rd International Online Conference on Genes (IOCGE 2026), organized by the open-access journal Genes (ISSN: 2073-4425; Impact Factor: 2.8) and published by MDPI. The conference will be held virtually from 2–4 December 2026.
Building on the success of previous editions, IOCGE 2026 will once again serve as a dynamic global forum for scientists and researchers to share their latest discoveries, foster collaborations, and engage in stimulating discussions on the most pressing topics in genetics.
The scientific program will feature sessions spanning the breadth and depth of the field, including the following:
This event offers a unique opportunity to present novel findings, exchange innovative methodologies, and explore the latest breakthroughs transforming our understanding of genes and their role in health and disease. By bringing together leading experts, early-career scientists, and practitioners worldwide, IOCGE 2026 aims to promote interdisciplinary dialogue and inspire new avenues for both basic research and clinical translation.
All accepted abstracts will be published online on Sciforum.net, ensuring broad visibility and lasting impact.
We warmly invite you to be part of IOCGE 2026 and look forward to your contributions to this exciting scientific exchange.
Kind regards,
Prof. Selvarangan Ponnazhagan
The University of Alabama at Birmingham, USA
Follow the conference organizer on Social Media
Event Chair
Department of Pathology, The University of Alabama at Birmingham, USA
Dr. Ponnazhagan is a trained molecular geneticist with a focus on cancer. He is currently a Full Professor and holds an Endowed Professorship in Experimental Cancer Therapeutics. The major research areas of Dr. Ponnazhagan’s lab are experimental cancer therapeutics, including stem cell and gene therapy using adeno-associated virus (AAV), tumor microenvironment (TME), and cancer bone metastasis. In reference to cancer-bone interaction, Dr. Ponnazhagan’s lab models breast cancer to adopt strategies that target tumor cells, immune suppression, and aggressive osteoclast functions. To overcome limitations in current therapies, his lab developed novel molecular tools and targeted delivery mechanisms, utilizing mesenchymal stem cells as effective therapeutic vehicles for bone remodeling in breast cancer osteolytic pathology. Towards targeting receptor activator of nuclear factor kappa-B ligand (RANKL) activation using osteoprotegerin (OPG), a decoy receptor for RANKL, without interfering in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of tumor cells, his lab developed an OPG mutant by structural protein engineering that lacks TRAIL binding affinity and validated in vivo in a disseminated osteolytic malignancy model. His group is the first one to identify a subset of immature myeloid cells, known as myeloid-derived suppressor cells, in the TME within the bone, directly undergo osteoclast differentiation and serve as osteoclast progenitors to enhance bone damage. Recent studies from his lab established the role of RANKL in activating M2 macrophages in breast cancer microenvironment and that dampening the effects of elevated RANKL using the OPG mutant resulted in a shift in the immune milieu favoring an anti-tumor cytokines and chemokine response.
Sessions
S2. Advances in Diagnosis, Treatment, and Prevention of Genetic Disorders
S3. Microbial Genetics and Metagenomics
S4. Epigenetics and Chromatin Remodeling
S5. Cancer Genetics
S6. Application of Machine Learning and Bioinformatics
S7. Population Genetics and Genetic Epidemiology
S8. Pharmacogenomics
Registration
The registration for IOCGE 2026 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 26 November 2026.
Instructions for Authors
The 3rd International Online Conference on Genes will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Deadline for abstract submission: 4 August 2026.
Abstract acceptance notification: 30 September 2026.
You will be notified of the acceptance of an oral/poster presentation in a separate email.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
- Should include the title, authors, contact details and main research findings, as well as tables, figures and graphs where necessary.
- Size in pixel: 1080 width x 1536 height–portrait orientation.
- Size in cm: 38, 1 width x 54, 2 height–portrait orientation.
- Font size: ≥16.
- Examples of successful submissions can be viewed here at the following links: (1), (2), (3).
- You can use our free template to create your poster.
The poster template can be downloaded HERE. We will reach out to you closer to the dates of the conference with more information.
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunity
1. Genes Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Special Issue (to be updated), published in Genes (ISSN: 2073-4425, Impact Factor 2.8), with a 10% discount on the publication fee. Please note, if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
2. Proceeding Paper Publication
If participants wish to publish an extended proceeding paper (4–8 pages) to Biology and Life Sciences Forum Proceedings (ISSN: 2673-9976), please submit it after the conference.
Authors are asked to disclose that it is a proceeding paper of the IOCGE 2026 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings submission deadline: 18 January 2027.
Title.
Full author names.
Affiliations (including full postal address) and authors' e-mail addresses.
Abstract.
Keywords.
Introduction.
Methods.
Results and Discussion.
Conclusions.
Acknowledgements.
References.
blsf-template.docx
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce the establishment of the Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
- Best Oral Presentation Award
Eligibility: Open to all authors selected as oral speakers who have delivered their presentation.
Criteria: Evaluation based on content quality, delivery clarity, audience interaction, and overall impact.
Prize: A prize of CHF 200 and a certificate celebrating your achievement.
- Best Poster Award
Eligibility: Open to all authors who have presented their work through posters.
Criteria: Evaluation based on scientific merit, creativity, and ability to attract and engage viewers.
Prize: A prize of CHF 200 and a certificate celebrating your achievement.
Winner Announcement: The award winners will be evaluated and selected by the scientific committee after the conference. Results will be announced on the website and all winners will be individually contacted via email.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
